Physician profile
Frances Bynum
NPI 1982691812
$162,312.52
in general payments reported to CMS, 2019-2025
12 companies · $21K in 2025
The $21K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $14K · 2021: $16K · 2022: $25K · 2023: $26K · 2024: $23K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $32K · Travel and Lodging: $19K · Consulting Fee: $8,715 · Honoraria: $7,383 · Food and Beverage: $2,274 · Entertainment: $66.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,760.00 |
| Travel and Lodging | $19,320.25 |
| Consulting Fee | $8,715.00 |
| Honoraria | $7,383.03 |
| Food and Beverage | $2,273.63 |
| Entertainment | $66.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $136,128.82 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Maculogix, INC. | $11,425.31 | 2019-2021 | |
| Lkc Technologies, INC. | $9,672.97 | 2022-2025 | |
| Integra Lifesciences Corporation | $4,285.04 | 2021-2025 | Omnigraft, Integra, Medihoney |
| Alcon Vision LLC | $277.33 | 2021-2025 | Precision 1, Total30, Precision7 |
| Biotissue Holdings INC. | $189.58 | 2025 | |
| Abbvie INC. | $145.47 | 2022 | |
| Optos, INC. | $66.50 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $51.83 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $42.55 | 2025 | Acthar |
| Oyster Point Pharma, INC. | $16.89 | 2023 | Tyrvaya |
| Lombart Brothers, INC. | $10.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frances Bynum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.